US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary: market research reports

RSS Feeds

Respiratory/Pulmonary market research reports and industry analysis

1    3    5  6  7  8  9  10  
2014 Opportunities in the US Respiratory Diseases Diagnostic Testing Market
12/6/2013 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and ...  |  read more...
$3,600.00
2014 Opportunities in the Italian Respiratory Diseases Diagnostic Testing Market
12/6/2013 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts, the report: ...  |  read more...
$1,950.00
Respiratory Partnering Terms and Agreements
12/1/2013 | published by: Current Partnering
... and analysis of how and why companies enter respiratory partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors respiratory ...  |  read more...
$2,995.00
Respiratory Tract Infections - Pipeline Review, H2 2013
11/30/2013 | published by: Global Markets Direct
... therapeutic development for Respiratory Tract Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Tract Infections. Respiratory Tract Infections ...  |  read more...
$2,000.00
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2013
11/30/2013 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
$2,500.00
Pulmonary Hypertension Global Clinical Trials Review, H2, 2013
11/30/2013 | published by: GlobalData
... information and data relating to the clinical trials on Pulmonary Hypertension . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The ...  |  read more...
$2,500.00
Pulmonary Fibrosis - Pipeline Review, H2 2013
11/30/2013 | published by: Global Markets Direct
... for Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Fibrosis. Pulmonary Fibrosis - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Acute Lung Injury - Pipeline Review, H2 2013
11/30/2013 | published by: Global Markets Direct
... therapeutic development for Acute Lung Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Lung Injury. Acute Lung Injury ...  |  read more...
$2,000.00
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H2 2013
11/30/2013 | published by: Global Markets Direct
... therapeutic pipeline. This report provides information on the therapeutic development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...  |  read more...
$2,000.00
Pulmonary Fibrosis Global Clinical Trials Review, H2, 2013
11/30/2013 | published by: GlobalData
... information and data relating to the clinical trials on Pulmonary Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
$2,500.00
Cough Global Clinical Trials Review, H2, 2013
11/30/2013 | published by: GlobalData
... relating to the clinical trials on Cough. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
$2,500.00
Inhalation & Nasal Spray Generic Drugs 2013
11/28/2013 | published by: Espicom Healthcare Intelligence
... in the treatment of asthma and chronic obstructive pulmonary disease (COPD) attracted combined revenues of around US$18.0 billion in 2012. All five are blockbuster drugs. The current market leader overall is GlaxoSmithKline’s Seretide/Advair (fluticasone propionate+salmeterol ...  |  read more...
$1,740.00
2014 Analysis of Respiratory Diseases in Germany: Market Outlook and Emerging Opportunities
11/25/2013 | published by: Venture Planning Group
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales forecasts, ...  |  read more...
$1,950.00
2014 Analysis of Respiratory Diseases in France: Market Outlook and Emerging Opportunities
11/25/2013 | published by: Venture Planning Group
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales forecasts, ...  |  read more...
$1,950.00
2014 Analysis of Respiratory Diseases in Spain: Market Outlook and Emerging Opportunities
11/25/2013 | published by: Venture Planning Group
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts, ...  |  read more...
$1,950.00
2014 Analysis of Respiratory Diseases in the US: Market Outlook and Emerging Opportunities
11/25/2013 | published by: Venture Planning Group
... sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to ...  |  read more...
$3,600.00
2014 Analysis of Respiratory Diseases in Japan: Market Outlook and Emerging Opportunities
11/25/2013 | published by: Venture Planning Group
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts, ...  |  read more...
$2,400.00
2014 Analysis of Respiratory Diseases in Italy: Market Outlook and Emerging Opportunities
11/25/2013 | published by: Venture Planning Group
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts, ...  |  read more...
$1,950.00
2014 Analysis of Respiratory Diseases in the UK: Market Outlook and Emerging Opportunities
11/25/2013 | published by: Venture Planning Group
... sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share ...  |  read more...
$1,950.00
2014 Analysis of the Respiratory Syncytial Virus Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
11/21/2013 | published by: Venture Planning Group
... Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5- ...  |  read more...
$4,350.00
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2013
11/15/2013 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Idiopathic Pulmonary Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
$2,500.00
Inhalation & Nasal Spray Generic Drugs: Potential Opportunities in the Respiratory Market
11/1/2013 | published by: Espicom Healthcare Intelligence
... The top five drugs used in the treatment of asthma and chronic obstructive pulmonary disease (COPD) attracted combined revenues of around US$18.0 billion in 2012. All five are blockbuster drugs. In terms of revenue, the ...  |  read more...
$1,740.00
Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2013
10/31/2013 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Pulmonary Arterial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
$2,500.00
Acute Lung Injury Global Clinical Trials Review, H2, 2013
10/31/2013 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Acute Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
$2,500.00
Respiratory Insufficiency Global Clinical Trials Review, H2, 2013
10/31/2013 | published by: GlobalData
... information and data relating to the clinical trials on Respiratory Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
$2,500.00
1    3    5  6  7  8  9  10  
 
Our Clients